Aripiprazole Oral Acceptability Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole

Tablets, Oral, 15 -30 mg, once daily, 2 weeks (days 1 -14).

DRUG

Aripiprazole

Oral Solution, Oral, 15-30 ml, once daily, 1 week (days 15 -21).

Trial Locations (7)

Unknown

Local Institution, Anaheim

Local Institution, National City

Local Institution, North Miami Beach

Local Institution, Overland Park

Local Institution, Staten Island

Local Institution, Oklahoma City

Local Institution, Falls Church

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY